- Home
- SANG vs BIOA Comparison
SANG vs BIOA Comparison
Compare SANG & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SANG | BIOA |
|---|---|---|
| Founded | 1984 | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.0M | 175.7M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | SANG | BIOA |
|---|---|---|
| Price | $5.37 | $12.97 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $11.33 |
| AVG Volume (30 Days) | 4.8K | ★ 403.7K |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $227,360,000.00 | $5,917,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.60 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.08 | $2.88 |
| 52 Week High | $7.99 | $13.10 |
Technical Indicators
Market Signals| Indicator | SANG | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 56.96 | 83.65 |
| Support Level | $5.07 | $12.00 |
| Resistance Level | $5.42 | $13.10 |
| Average True Range (ATR) | 0.13 | 0.72 |
| MACD | 0.03 | 0.32 |
| Stochastic Oscillator | 91.26 | 97.20 |
Price Performance
Historical ComparisonAbout SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.
About BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.